Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 36%Whether you are a trader or an investor, there is one thing to watch carefully in the coming days: Earnings. The reason why this is importa...
17 Apr, 2026, 11.04 PM IST
Children’s ibuprofen recalled in 2026: Nearly 90,000 bottles of pain-relieving medication pulled nationwideChildren's ibuprofen recalled: A major recall impacts nearly 90,000 bottles of children's ibuprofen oral suspension. The medication, manufa...
20 Mar, 2026, 10.05 AM IST
Lupin launches generic drug to treat urea cycle disorders in USDrug firm Lupin has launched a generic medication in the US. This new drug treats urea cycle disorders. It is an authorized generic version...
24 Oct, 2025, 12.10 PM IST
Zydus Lifesciences shares in focus after 2 regulatory approvals from Health Canada, USFDAZydus Life shares: Zydus Lifesciences received regulatory approvals from Health Canada for generic Liothyronine tablets and from the USFDA ...
07 Oct, 2025, 09.01 AM IST
Granules India gets USFDA nod for generic Glycopyrrolate oral solutionGranules Pharmaceuticals Inc, a subsidiary of Granules India, has received approval from the USFDA for a generic Glycopyrrolate oral soluti...
20 Aug, 2024, 03.16 PM IST
Strides Pharma unit gets USFDA nod for generic drug to treat gastrointestinal diseasesStrides Pharma Science on Wednesday said its unit has received approval from the US health regulator to market a generic medication used in...
22 May, 2024, 03.32 PM IST
Bharat Parenterals gets DCGI nod for favipiravir oral suspensionThe company has received licence and authorisation from DCGI to manufacture and market favipiravir oral suspension l00mg/ml, Bharat Parente...
22 May, 2021, 08.15 PM IST
Strides Pharma Science arm gets American drug regulator's nod for pain relieving drugStrides Pharma Global Pte. Limited, Singapore, has received approval for Ibuprofen Oral Suspension USP, 100 mg/5 mL from the United States ...
24 Feb, 2021, 11.16 AM IST
Take care of your teeth: Poor dental health may up hypertension riskPeople with periodontal disease were 20 per cent less likely to reach healthy BP ranges.
23 Oct, 2018, 06.31 PM IST
Aurobindo Pharma gets USFDA nod for infections treatment drugThe company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Azithromycin Oral suspen...
11 Oct, 2018, 02.30 PM IST
Lupin launches voriconazole tabletsThe medicines are indicated for use in patients 12 years of age and older in the treatment of fungal infections, including invasive Aspergi...
19 Dec, 2016, 01.00 PM IST
Lupin gets USFDA nod for fungal infection drugThe company's products are generic versions of PF Prism C.V's Vfend tablets and Vfend oral suspension in the same strengths, report added.
22 Jun, 2016, 05.02 PM IST
Glenmark gets tentative nod from USFDA for epilepsy drugThe company will market this product upon receiving final approval of Lacosamide Oral solution, 10 Mg/mL.
18 Mar, 2016, 11.46 AM IST
Aurobindo Pharma gets USFDA nod to sell antibiotic oral suspensionThe approval by the USFDA is for strengths of 100 mg/5 ml and 200 mg/5 ml and the product is ready for launch, Aurobindo Pharma said in a s...
15 Apr, 2015, 01.44 PM IST
Lupin launches generic Ciprofloxacin in US marketThe company had earlier received final approval for the product from the United States Food and Drug Administration (USFDA), it added.
13 Jun, 2014, 04.26 PM IST
Aurobindo Pharma gets USFDA nod for Cefadroxil oral suspensionThe product is the generic equivalent of Warner Chilcott Company Inc's Duricef for oral suspension in the same strengths.
26 Apr, 2013, 02.27 PM IST
- Ranbaxy gets USFDA nod for Clarithromycin oral suspension
Ranbaxy Laboratories has received final approval from the US Food and Drug Administration to manufacture and market Clarithromycin for oral...
04 Oct, 2007, 01.05 PM IST